Smith & Nephew management has 'uninspiring' analyst meeting; AT&T, Calgary Scientific link up on app;

> Smith and Nephew and analysts had what the latter called an "uninspiring" meeting. Credit Suisse analyst Christoph Gretler said the bank would maintain its neutral rating on S&N "having attended a rather uninspiring roundtable with chief executive Olivier Bohuon and chief financial officer Adrian Hennah in London." Story

> AT&T is linking up with Calgary Scientific for the latter's ResolutionMD app. The ResolutionMD mobile component should be available to AT&T medical imaging users during the H1 2012. Report

> Japan's Miraca Holdings has completed its buy of Caris Life Sciences' anatomic pathology business for $725 million. Item

> OrthoAccel Technologies has received FDA clearance for AcceleDent system, an appliance designed to accelerate orthodontic treatment, and is preparing to launch the product. OrthoAccel release

> The FDA has cleared the Canon CXDI-80C wireless digital radiography detector and the CXDI-501 series DR detectors. Canon release

> Searchlight Capital will resume trading under the symbol "LMD" (LED Medical Diagnostics), as a Tier 2 industrial issuer. Trading will begin again within a few days of the issuance of a Final Exchange Bulletin by the TSX Venture Exchange. Searchlight release

> An Australian Senate committee has recommended that doctors in that country be required to report any problems they observe with medical devices to the TGA. News

> Austin, TX-based Freescale Semiconductor has launched a home health hub reference platform to help medical equipment makers create remote-access devices that can collect, connect and securely share health data. Story

And Finally... Nimbic Systems' Air Barrier System will be featured on the show The Doctors this week. Dr. Terry Clyburn will demonstrate how the system works and discuss how it prevents the intrusion of bacteria into incision sites during joint replacement surgery. Report

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.